Title
Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon
Date Issued
01 June 2010
Access level
open access
Resource Type
journal article
Author(s)
Grietens K.P.
Erhart A.
Ribera J.M.
Toomer E.
Tenorio A.
Rodriguez H.
D'Alessandro U.
Abstract
Despite being free of charge, treatment adherence to 7-day primaquine for the radical cure of Plasmodium vivax was estimated at 62.2% among patients along the Iquitos-Nauta road in the Peruvian Amazon. The principal reason for non-adherence was the perceived adverse effects related to local humoral illness conceptions that hold that malaria produces a hot state of body, which is further aggravated by the characteristically hot medical treatment. Notably, patients were willing to adhere to the first 3 days of treatment during which symptoms are most apparent and include the characteristic chills. Nevertheless, as symptoms abate, the perceived aggravating characteristics of the medication outweigh the perceived advantages of treatment adherence. Improving community awareness about the role of primaquine to prevent further malaria transmission and fostering a realistic system of direct observed treatment intake, organized at community level, can be expected to improve adherence to the radical cure of P. vivax in this area. Copyright © 2010 by The American Society of Tropical Medicine and Hygiene.
Start page
1017
End page
1023
Volume
82
Issue
6
Language
English
OCDE Knowledge area
Parasitología
Políticas de salud, Servicios de salud
Scopus EID
2-s2.0-77953802828
PubMed ID
Source
American Journal of Tropical Medicine and Hygiene
ISSN of the container
00029637
Sponsor(s)
Instituto Nacional de Alergias y Enfermedades Infecciosas R01AI067727 NIAID
Sources of information:
Directorio de Producción Científica
Scopus